Barry S Skikne MD

Physician

3901 Rainbow BlvdKansas City, KS 66160
Phone+1 913-588-6000

Dr. Skikne is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Skikne's full profile Already have an account?

Education & Training

University of Kansas School of MedicineFellowship, Hematology and Medical Oncology, 1977 - 1979
University of the WitwatersrandClass of 1969

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

KS State Medical License 1978 - 2027

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2017
CMS Meaningful Use Stage 1 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2017
Top MD Consumers Checkbook

Clinical Trials

Safety, Pharmacokinetics, and Pharmacodynamics of Oral Azacitidine in Subjects With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia and Acute Myelogenous Leukemia Start of enrollment: 2007 Sep 11
COMPLETED
PHASE1
Safety & Pharmacokinetics Study Of Azacitidine (SC And Oral) In Subjects With MDS, CMML, AML, Lymphoma And Multiple Myeloma Start of enrollment: 2008 Aug 12
COMPLETED
PHASE1
Study to Evaluate Pharmacokinetics, Food Effect, Safety and Efficacy of Oral Azacitidine Start of enrollment: 2012 Feb 07
COMPLETED
PHASE1

Publications & Presentations

PubMed

1 citations
Efficacy and Safety of Daratumumab, Pomalidomide and Dexamethasone Compared to Daratumumab, Carfilzomib and Dexamethasone in Relapsed Multiple Myeloma: Multicenter Rea...
Anas Zayad, Gray Magee, Razan Mansour, Mark Chang, Nausheen Ahmed
Clinical Lymphoma, Myeloma & Leukemia. 2026-02-01
The Impact of Sponsors on Development of Clinical Research in Multiple Myeloma and AL Amyloidosis: An In-Depth Analysis.
Anas Zayad, Nausheen Ahmed, Zahra Mahmoudjafari, Barry S Skikne, Tara Lin
Clinical Lymphoma, Myeloma & Leukemia. 2025-08-01
5 citations
Phase 1 dose escalation study of the MDM2 inhibitor milademetan as monotherapy and in combination with azacitidine in patients with myeloid malignancies.
Courtney D DiNardo, Rebecca Olin, Eunice S Wang, Barry Skikne, Joseph Rosenthal
Cancer Medicine. 2024-07-01

Abstracts/Posters

Preliminary Results from a Phase II Study of the Combination of Pevonedistat and Azacitidine in the Treatment of MDS and MDS/MPN after Failure of DNA Methyltransferase...
Barry S. Skikne, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
LAG3 Inhibition Decreases AML-Induced Immunosuppression and Improves T Cell-Mediated Killing
Barry S. Skikne, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019